SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Restructurings
An SI Board Since September 2002
Posts SubjectMarks Bans
270 25 0
Emcee:  rkrw Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
70Out here in biopharm operations land, the view is not that bleak: bio/pharma proHarold Engstrom-1/14/2003
69Biotech firms hand out the pink slips Uncertainty over future funding is promptiIcebrg-1/14/2003
68Ontogen, 90 %. By Mike Freeman UNION-TRIBUNE STAFF WRITER January 9, 2003 OntIcebrg-1/13/2003
67Don't get too carried away with the conservatism, I date someone who works iscaram(o)uche-1/8/2003
66QGENF <5% Message 18417320 Not that QGENF, which is easily cash flow and eatuck-1/8/2003
65TXBI, 29% HOUSTON, Jan. 7 /PRNewswire-FirstCall/ -- Texas Biotechnology Corporanigel bates-1/7/2003
64KERX - just about 50% NEW YORK, Jan. 2 /PRNewswire-FirstCall/ -- Keryx Biopharmnigel bates-1/2/2003
63ABI 9% Message 18376435 Cheers, Tucktuck-12/27/2002
62Targeted Genetics 40% Targeted Genetics Adjusts Business Strategy to Pursue NeaIcebrg-12/17/2002
61Even Millennium! 4% Millennium Pharmaceuticals to Cut 103 Jobs in Shift to ProdIcebrg-12/16/2002
60CALP, 10% This is a little stale -- September -- but better late than never: Mtuck-12/14/2002
59Inhale Therapeutic Systems 10 % SAN CARLOS, Calif. (Dow Jones)--Inhale TherapeuIcebrg-12/11/2002
58Xenova cuts 40 jobs to help conserve cash (no % given in the original PR) - LONnigel bates-12/11/2002
57ArQule Announces Restructuring to Focus on Current Partnerships and Internal DruIcebrg-12/10/2002
56DRRX 11/22 16% Press Release Source: DURECT Corporation DURECT Corporation Inrkrw-11/22/2002
55QLTI 18% >>VANCOUVER, Nov. 21 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: tuck-11/22/2002
54TWTI, 43% genomeweb.com Cheers, Tucktuck-11/18/2002
53When xeno was spun out (Immerge), it left a natural shell. There was no remainiscaram(o)uche-11/15/2002
52As stefaan puts it, BTRN does an NTII: Message 18237093 Cheers, Tucktuck-11/15/2002
51Photogen Restructures and Completes $9 Million Financing Friday November 15, 8:0Icebrg-11/15/2002
50Genstar 30% They had a promising looking gene therapy for hemophilia in PI; nottuck-11/14/2002
49Maxygen Increases Focus on Advancing Key Therapeutic Products And Reducing CostsIcebrg-11/13/2002
48Incyte Genomics to cut staff 37 pct, loss widens Tuesday November 12, 4:54 pm ETIcebrg-11/12/2002
47Quintiles Rejects $1.3 Billion Bid November 11, 2002 6:00:00 PM ET RESEARCH TRDoc Bones-11/12/2002
46>>MEDX ? >> I would be surprised if it wasn't. DD likes to talkIcebrg-11/8/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News